Background: Wheezing illnesses among young children are common and are a risk
than the children without sensitization. No other significant associations were found.
Conclusions: Atopic sensitization at the time of the first severe wheezing episode is an important early risk factor for increased bronchial reactivity at preschool age.
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| INTRODUCTION
Previous studies have shown that early wheezing induced by rhinovirus and/or associated with sensitization is an important risk factor for recurrent wheezing and asthma. They are likely to reveal the underlying airway inflammation and the weaknesses in viral defense mechanisms. [1] [2] [3] However, the factors influencing bronchial reactivity in children are poorly characterized. Previous studies have shown that early-life factors, such as early-onset atopy, [4] [5] [6] [7] family history of asthma, 6, 8 maternal smoking, [4] [5] [6] 8, 9 exposure to traffic-related air pollution, 10 ,11 preterm birth, [12] [13] [14] and low birth weight, 15 may be associated with decreased pulmonary function in later childhood. Two studies have shown that wheezing at young age, induced by rhinovirus, may be associated with decreased pulmonary function or increased airway reactivity later in childhood. 8, 16 Some 5, 17, 18 but not all 9, 19 studies have shown a comparable association between respiratory syncytial virus (RSV)-induced wheezing and reduced pulmonary function. However, these earlier studies mainly included older children, and there were no data from the first virus-induced wheezing episode.
Pulmonary function testing in young children is challenging.
Impulse oscillometry (IOS) is a method for testing pulmonary function during tidal breathing. [20] [21] [22] [23] A key measurement in IOS is respiratory resistance (Rrs) which indicates the energy loss due to resistive forces to the airflow in the airways and is clinically interpreted as an indicator of obstruction. IOS is child-friendly as it requires a minimum cooperation and has successfully been used from the age of 2-3 years forward. 21, 24 In Finland, there are population-based reference values available for children aged 2-7 years. 20, 23 Secondary strategies to prevent asthma can be initiated at the time of the first wheezing episode. [25] [26] [27] [28] However, it is not known which patient characteristics at the time of the first acute wheezing episode predict abnormal pulmonary function during the later childhood. Thus,
G R A P H I C A L A B S T R A C T
Vinku2 is the first study to investigate the associations between the patient characteristics of the first acute severe virus-induced wheezing episode and the subsequent pulmonary function and bronchial reactivity. Atopic sensitization diagnosed during the first acute severe wheezing episode was associated with increased bronchial reactivity and reduced lung function at preschool age. These results are important to consider for the design of early intervention trials for the secondary prevention of asthma.
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| 519 among children who had suffered from the first acute severe wheezing episode before the age of 2 years, we aimed to determine the pulmonary function at the age of 5 years and its reactivity to exercise or bronchodilation by IOS. We also tested for early-life factors predicting the exercise or bronchodilation-induced bronchial reactivity. We hypothesized that patient characteristics, such as rhinovirus etiology and atopy at the time of the first severe wheezing episode, would be associated with the pulmonary function and increased bronchial reactivity measured by IOS 4 years after the first wheezing episode.
2 | ME TH ODS
| Subjects
This study is a part of a larger Vinku2 study which was carried out in treated at emergency room of tertiary hospital) using a randomized double-blind placebo-controlled paralleled design. The inclusion criteria were age 3-23 months, first acute wheezing episode (confirmed by parental report and medical records), and delivery at ≥36 weeks. Children with chronic nonatopic illnesses, need for intensive care unit treatment, or previous systemic or inhaled corticosteroid (ICS) treatment were excluded from the study. The study was approved by the Ethics Committee of the Turku University Hospital and was commenced after obtaining written informed consent from guardians. The trial was double-blinded until the 12-month follow-up.
| Study protocol
At study entry, the guardian completed a standard questionnaire form, the child was physically examined, a nasopharyngeal aspirate sample was taken using a standardized procedure, 30 
| Laboratory methods

| Impulse oscillometry
The airway hyperresponsiveness and reversible airflow obstruction were measured using IOS. [20] [21] [22] [23] The impulse oscillatory signals of 5- Xrs decreases due to peripheral stiffening as a result of obstruction. The technical realization of IOS is described in more detail in Appendix S1.
After the baseline measurements, a 6-minute exercise test was conducted. The children were urged to run 6-8 min at an exercise level where the heart rate was held at 85%-90% of their estimated maximum heart rate (205−1/2 × age), assessed with a heart rate monitor 
| Definitions
Children had atopic sensitization if they had a positive test (cutoff level ≥0.35 kU/L) for IgE specific for any of tested allergens (codfish, cow's milk, egg, peanut, soybean, wheat, cat, dog, horse, birch, mugwort, timothy, Cladosporium herbarum, and Dermatophagoides pteronyssinus). 29 Eczema at study entry was a physician-made diagnosis according to pruritus, typical morphology, and chronicity of disease and it was defined as atopic if any sensitization was diagnosed.
| Statistical methods
Baseline differences between groups of different characteristics were analyzed with two-sample t-test (normally distributed variables), (95%) children. Exercise test was not conducted due to refusal of running in two (3%) children and due to severe asthma symptoms in one (1%) child. All the children with bronchodilation and/or exercise test (n = 76) were included in the analysis. The included (n = 76) and excluded (n = 48) participants did not differ from one another concerning the patient characteristics shown in Table 1 (Table S1 ).
| Patient characteristics
At study entry, the mean age of the 76 study subjects was had aeroallergen sensitization, and 21/74 (28%) had food sensitization (Table 1) .
At the 4-year follow-up visit, the mean age of the children was 60 months (SD 7.9 months). Thirty-seven (49%) children used ICS treatment during the 12 months preceding the 4-year follow-up visit.
Asthma medication was discontinued ≥4 weeks prior to the exercise testing in 25 children (68% of the children using ICS) ( Table S2 . Children who had atopic eczema (β −0.74; 95%CI −1.4 to −0.11; P = 0.022) or seasonal atopic sensitization (β −1.1; 95%CI −2.1 to −0.14; P = 0.025) at study entry had lower Xrs 5 Hz z-score at baseline measurement than the children with no atopic eczema or seasonal sensitization, respectively. These results, however, were not statistically significant in multivariable analyses which included age, OCS for the first wheezing episode, rhinovirus etiology, and ICS use 4 weeks before the oscillometry. In multivariable analysis, age at study entry for acute wheezing was associated with decreased Xrs 5 Hz (β −0.052; 95%CI −0.095 to −0.009; P = 0.019); that is, the older the age at study entry, the lower the compliance of the lung tissue due to small airway obstruction. Other factors, such as virus etiology, shown in Table 2 were not associated with the baseline values of IOS (Table S3 ). Baseline Rrs 10 values were not associated with any of the factors shown in Table 2 (data not shown).
| Bronchial reactivity
Increased bronchial reactivity was diagnosed in 9/75 (12%) children.
Eight (11%) of these changes were diagnosed in the exercise test as a Rrs 5 Hz increase of ≥35%, and one (1%) of the children had a Rrs 5 Hz decrease of ≥35% following administration for salbutamol.
Increased bronchial reactivity induced by exercise was more common in children who had atopic eczema (OR 14; 95%CI 2.7 to 72; P = 0.002) or atopic sensitization (OR 10; 95%CI 1.8 to 55; P = 0.008) at the time of the first wheezing episode. The association with atopic sensitization (OR 8.8; 95%CI 1.2 to 64; P = 0.032) remained in multivariable analysis which included age at study entry, OCS for the first wheezing episode, atopic sensitization, and rhinovirus etiology at study entry ( Table 2 In adjusted analysis, which included age at study entry, hospitalization, OCS use at study entry, ICS use within 4 weeks, atopic sensitization at study entry, and rhinovirus etiology, atopic sensitization remained statistically significant (β 0.54; 95%CI 0.027 to 1.1; P = 0.027). The changes in postbronchodilator values were not affected by any of the factors shown in Table 2 (Table S3 ). Postexercise or postbronchodilator Rrs 10 values were not affected by any of the factors shown in Table 2 (data not shown).
There were no statistically significant differences in bronchial reactivity depending on the age, sex, or virus etiology. However, all 8 children with pathological exercise-induced bronchial reactivity (≥35%) were rhinovirus positive during the first wheezing episode.
Likewise, other patient characteristics shown in Table 1 were not associated with bronchial reactivity.
| The effect of corticosteroid treatment
The OCS treatment during the first wheezing episode did not affect the pulmonary function four years later. There were no significant differences in baseline IOS parameters (all P ≥ 0.13) or in exerciseinduced bronchial reactivity (P ≥ 0.16) between the prednisolone and placebo groups. In the 12 children who were not able to discontinue the ICS use, the exercise-induced change in Rrs 5 Hz was greater than that in non-ICS users (β 0.70; 95%CI 0.080 to 1.3; P = 0.028), but this association did not remain in adjusted analysis (Table 2 , Table S3 ). The results without the children using continuous ICS treatment before the follow-up visit were not markedly different (data not shown).
| DISCUSSION
To our knowledge, this is the first study to investigate the associations between the patient characteristics of the first acute severe virus-induced wheezing episode and the subsequent pulmonary function and bronchial reactivity later in childhood. As a main finding, atopic sensitization, both aeroallergen and food sensitization, during the first wheezing episode was associated with increased bronchial reactivity at preschool age. We did not find any significant association between the rhinovirus or its genome load, other virus infections, or other patient characteristics at study entry and the later pulmonary function or bronchial reactivity.
Previous studies have reported that the early atopic sensitization is an important predictor for reduced pulmonary function in later life. 4 For baseline values, 2-sample t-test and linear regression analysis were used and results are expressed as regression coefficient beta or mean difference and 95% confidence intervals. For postexercise values, logistic regression analysis was used and results are reported as odds ratios and 95% confidence intervals. Earlier studies have shown decreased baseline pulmonary function in 20%-29% of cases 6-8 years after virus-induced bronchiolitis. 8, 9, 19 In our study, the proportion of pathological pulmonary function at baseline was low (3%). Our detection rate of exerciseinduced bronchial reactivity (11%) is also relatively low when compared to earlier studies (13%-62%). 8, 9, 19 In our study, twelve (32%) of the 37 children were not able to discontinue the ICS medication for asthma, which may partly explain the low detection rate of increased bronchial reactivity. However, in majority (68%) of the children using ICS, the medication was discontinued at least four weeks before the IOS testing. According to the Finnish guidelines, 41 Strengths of our study include the prospective design, new focus on the first wheezing episode, comprehensive viral diagnostics, the use of IOS for pulmonary function testing, good quality of the IOS measurements, and discontinuation of regular asthma controller medication in majority of asthmatic children before testing. Allergen-specific IgE was used for characterization of atopic sensitization. The children were carefully examined by a physician, and the standard questionnaire was used which provided detailed characterization of the children. 42 However, our study has some limitations. Most patients were hospitalized during the first acute wheezing episode, which makes these results only applicable for the most severe end of illness.
The relatively small study population precluded analysis of rhinovirus species or the associations of other respiratory viruses with spirometry outcomes. Reasonable challenge in exercise test was ensured by continuous heart rate monitoring, but ventilation was not measured for this purpose.
In conclusion, atopic sensitization diagnosed during the first acute severe wheezing episode was associated with increased bronchial reactivity and reduced lung function at preschool age. Clinically, these results suggest that testing for atopic sensitization at the time of first wheezing episode may have prognostic significance with respect to lung function. These results are also important to consider for the design of early intervention trials for secondary prevention of asthma.
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